Skip to main content

Table 1 Criteria for diagnosis of metabolic syndrome

From: Prevalence of undiagnosed metabolic syndrome using three different definitions and identifying associated risk factors among apparently healthy adults in Karachi, Pakistan: a cross-sectional survey in the year 2022

 

Metabolic Syndrome

Waist Circumference (WC)

Blood Pressure (BP)

Fasting Plasma Glucose

Triglyceride (TG)

HDL-C

NCEP-ATP III (2001)

Presence of at least 3 RF

For Males ≥ 102 cm,

For Females ≥ 88 cm

SBP ≥ 130 mm/Hg and/or

DBP ≥ 85 mm/Hg

≥ 110 mg/dL

(≥ 6.1 mmol/L)

≥ 150 mg/dL (≥ 1.7 mmol/L)

For Males

< 40 mg/dL

(< 1.03 mmol/L),

For Females

< 50 mg/dL

(< 1.29 mmol/L)

IDF (2005)

WC with 2 or more other RF

For Males ≥ 90 cm,

For Females ≥ 80 cm

SBP ≥ 130 mm/Hg and/or

DBP ≥ 85 mm/Hg or on treatment for hypertension

≥ 100 mg/dL

(≥ 5.6 mmol/L) or previously diagnosed T2DM

≥ 150 mg/dL (≥ 1.7 mmol/L) or on treatment for TG

For Males

< 40 mg/dL

(< 1.03 mmol/L),

For Females

< 50 mg/dL

(< 1.29 mmol/L) or on treatment for HDL-C

Modified NCEP-ATP III (2005)

Presence of at least 3 RF

For Males ≥ 90 cm,

For Females ≥ 80 cm

SBP ≥ 130 mm/Hg and/or

DBP ≥ 85 mm/Hg or on treatment for hypertension

≥ 100 mg/dL

(≥ 5.6 mmol/L) or previously elevated glucose

≥ 150 mg/dL (≥ 1.7 mmol/L) or on treatment for TG

For Males

< 40 mg/dL

(< 1.03 mmol/L),

For Females

< 50 mg/dL

(< 1.29 mmol/L) or on treatment for HDL-C

  1. DBP: Diastolic blood pressure, HDL: High-Density Lipoprotein, NCEP-ATP III: National Cholesterol Education Program for Adult Treatment Panel, RF: Risk Factors, SBP: Systolic blood pressure